Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Glenn Baity currently holds 83,734 shares of ACADIA PHARMACEUTICALS INC (ACAD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Glenn Baity has been a net seller of ACAD stock. They have purchased $0 and sold $13.2M worth of shares.
Glenn Baity's most recent insider trade was on Jan 29, 2018, when they sold 36,558 shares at $32.39 per share.
Glenn Baity serves as Executive at ACADIA PHARMACEUTICALS INC (ACAD). They have executed 68 insider transactions totaling $13.2M over their tenure at the company.
Glenn Baity holds the position of Executive at ACADIA PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Glenn Baity has shown a selling trading pattern, with $0 in total purchases and $13.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Glenn Baity was on Jan 2, 2018, when they sold $2.2M worth of ACAD shares. This transaction involved 74,321 shares at $30.14 per share.
Glenn Baity currently owns 83,734 shares of ACADIA PHARMACEUTICALS INC (ACAD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Glenn Baity's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Glenn Baity has 68 Form 4 filings on record as an insider at ACADIA PHARMACEUTICALS INC.
Set alerts for Glenn Baity and 40,000+ other insiders.